Skip to Content

Solriamfetol use while Breastfeeding

Drugs containing Solriamfetol: Sunosi

Medically reviewed by Drugs.com. Last updated on March 1, 2021.

Solriamfetol Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of solriamfetol during breastfeeding. If solriamfetol is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the breastfed infant for adverse reactions, such as agitation, insomnia, poor feeding, and reduced weight gain.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

(Narcolepsy) Amphetamine, Armodafinil, Dextroamphetamine, Lisdexamfetamine, Methylphenidate, Modafinil

Substance Identification

Substance Name

Solriamfetol

CAS Registry Number

178429-62-4

Drug Class

  • Breastfeeding
  • Lactation
  • Adrenergic Agents
  • Carbamates
  • Central Nervous System Stimulants
  • Dopamine Agents
  • Wakefulness-Promoting Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.